Description: This article attempts to make a modest contribution to the dialogue on the potential and risks associated with novel treatments such as cell & gene therapies. With a fast-expanding roster of what are believed to be one-time treatments at ever increasing price points aimed at curing a wider swatch of the population, they are as much a source of relief for patients stuck in medical limbo, as they are a source of anxiety for payers.

Description: This article provides an overview of activities that should be considered by an actuary when validating a predictive model. It describes several components to consider when validating a predictive model and provides an examination of various methodologies that can be implemented in the validation process.

Description: The global nature of the reinsurance industry has enabled the diversification of risk away from concentration in specific regions to the larger global market. However, record catastrophe losses, inflation stemming from increased interest rates, geopolitical tensions and heightened climate risk are putting operating pressures on insurers and reinsurers. Article discusses the implications.

Description: Subtitle: My real-life connection to (almost) every supplemental product Data is king, but maybe it should be dethroned once in a while so we can better understand the "why" behind the data.

Description: The insurance industry is undergoing a profound transformation, driven by a rapidly evolving landscape that is reshaping the way insurers market and distribute their products. This article delves into the key trends and factors shaping the industry, exploring the implications for insurance companies as they adapt to the changing environment.

Description: A recounting of all the accomplishments the Joint Risk Management Section had in 2021 crediting those responsible for their successful completion.

Description: View the Archive Spring 2022: GH Group and Health Design and Pricing Exam

Description: View the Archive Spring 2022: RET Design and Accounting Exam US.

Description: We explore the question of how an actuary–artificial intelligence collaboration might look in the future and how actuaries should be trained to best leverage this technology. It felt fitting to accomplish this through a conversation with an AI system, as AI involvement is warranted to ground the analysis in the technology’s true capabilities.

Description: Actuaries with Medicare expertise regularly receive information specific to either Part C or Part D, but a key component of successful bid preparation is effective coordination between these two programs. This article explores pricing and regulatory common ground between Part C and Part D bids to aid actuaries as they guide decisions impacting both benefits.